Suchergebnisse - "Emile, J.F."

PubPharm (219)

1

Trop-2 is a ubiquitous and promising target in pancreatic adenocarcinoma

enthalten in: Clinics and research in hepatology and gastroenterology | 2023

von Mas, L. | Cros, J. | Svrcek, M. | +5

2

Tumor budding is an independent prognostic factor in stage III colon cancer patients : a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Basile, D. | Broudin, C. | Emile, J. | +14

3

Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancer

enthalten in: Translational oncology | 2022

von Nicolle, R. | Gayet, O. | Bigonnet, M. | +19

4

PACpAInt: a deep learning approach to identify molecular subtypes of pancreatic adenocarcinoma on histology slides

enthalten in: bioRxiv.org | 2022

von Saillard, C. | Delecourt, F. | Schmauch, B. | +21

5

Second primary cutaneous melanoma in patients with advanced melanoma treated with anti-programmed-death-receptor-1 monoclonal antibodies

enthalten in: The British journal of dermatology | 2021

von Charvet, E. | Kramkimel, N. | Chaplain, L. | +13

6

A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Nicolle, R. | Gayet, O. | Duconseil, P. | +24

CommentIn: Ann Oncol. 2021 Feb;32(2):133-135. - PMID 33227409

7

Second primary cutaneous melanoma in patients with advanced melanoma treated with anti‐programmed‐death‐receptor‐1 monoclonal antibodies

enthalten in: British Journal of Dermatology | 2021

von Charvet, E. | Kramkimel, N. | Chaplain, L. | +13

8

A tularemia mimicking lymphoma

enthalten in: La Revue de medecine interne | 2020

von Chevalier, K. | Venon, M. | Émile, J. | +6

9

Corrigendum to 'Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study' : Annals of Oncology 2020; Volume 31: 921-929

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Pagès, F. | André, T. | Taieb, J. | +18

ErratumFor: Ann Oncol. 2020 Jul;31(7):921-929. - PMID 32294529

10

Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Pagès, F. | André, T. | Taieb, J. | +18

ErratumIn: Ann Oncol. 2020 Sep;31(9):1276. - PMID 32653357

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]